Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Patients with mild COVID-19; ? Age 18-80 years old; ? Voluntarily accept treatment and sign informed consent.
Exclusion criteria
Exclusion criteria: ? delirious, consciousness disorder, dementia, all kinds of mental patients; ? Pregnant and lactating women; ? Patients with active pulmonary tuberculosis, pulmonary abscess and chronic respiratory failure; ? Patients with tumor; ? Patients with severe liver and kidney diseases; ? patients with severe cardiovascular and cerebrovascular diseases; ? those who are taking part in clinical trials of other drugs and are known to be allergic to the treatment drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nucleic acid turning negative time;Nucleic acid conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cumulative incidence of adverse events;rate to the normal/heavy;Time/rate of the abatement of fever;Time/rate of clinical symptom remission; | — |
Countries
China